Targeting CCR2/5 in the treatment of nonalcoholic steatohepatitis (NASH) and fibrosis: opportunities and challenges

著录项

• 来源
  《Expert opinion on investigational drugs》 |2020年第6期|89-92|共4页
• 作者

  Lefere Sander; Devisscher Lindsey; Tacke Frank;

  展开▼
• 作者单位

  Univ Ghent, Hepatol Res Unit, Dept Gastroenterol & Hepatol, Ghent, Belgium;

  Univ Ghent, Gut Liver Immunopharmacol Unit, Dept Basic & Appl Med Sci, Ghent, Belgium;

  Charite Univ Med Ctr, Dept Hepatol & Gastroenterol, Augustenburger Pl 1, D-13353 Berlin, Germany;

  展开▼
• 收录信息
• 原文格式 PDF
• 正文语种 英语
• 中图分类 药学;
• 关键词

  Nonalcoholic steatohepatitis; liver fibrosis; pharmacotherapy; hepatocellular carcinoma; cenicriviroc; NAFLD; macrophage; CCR2 inhibition; CCR5 inhibition;

• 入库时间 2024-01-25 00:28:40